Manning Paul B 13D/13G Filings for Pasithea Therapeutics Corp. (KTTA)

Manning Paul B 13D and 13G filings for Pasithea Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-14
6:28 pm
Unchanged
2022-10-2213GPasithea Therapeutics Corp.
KTTA
Manning Paul B170,435
11.300%
0
(Unchanged)
Filing
2022-06-29
4:30 pm
Purchase
2022-06-2213GPasithea Therapeutics Corp.
KTTA
Manning Paul B170,435
9.800%
170,435increase
(New Position)
Filing